- Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: tiotropium; Drug: olodaterol; Drug: olodaterol; Drug: olodaterol; Drug: tiotropium; Drug: tiotropium; Drug: olodaterol; Drug: tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: exercise
Sponsors: Laval University; Laval University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: PH-797804; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium; Drug: Olodaterol; Drug: Tiotropium; Drug: tiotropium + olodaterol; Drug: Olodaterol; Drug: Olodaterol; Drug: tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: olodaterol; Drug: olodaterol; Drug: Tiotropium; Drug: Tiotropium; Drug: Oldaterol; Drug: Tiotropium + olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium+olodaterol; Drug: tiotropium + olodaterol (high dose); Drug: placebo to tiotropium+olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: COPD
Interventions: Drug: GSK573719/GW642444; Drug: GSK573719
Sponsors: Queen's University; Queen's University; GlaxoSmithKline
Not yet recruiting - verified December 2011 - Conditions: Chronic Obstructive Pulmonary Diseases; Chronic Airways Limitation; Bronchitis
Interventions: Drug: Mepolizumab; Drug: placebo
Sponsors: McMaster University; McMaster University
Recruiting - verified October 2011 - Condition: Respiratory Syncytial Virus, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure
Intervention:
Sponsors: MedImmune LLC; MedImmune LLC; AstraZeneca AB
Recruiting - verified April 2012 - Conditions: COPD; COPD Exacerbation; Lung Diseases; Respiratory Disorders; Pulmonary Disease; Chronic Obstructive Lung Diseases; Chronic Obstructive Airway Disease
Interventions: Drug: Roflumilast; Drug: Placebo
Sponsors: Forest Laboratories; Forest Laboratories
Recruiting - verified March 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide; Drug: Formoterol Fumarate; Drug: placebo
Sponsors: Forest Laboratories; Forest Laboratories; Almirall, S.A.
Recruiting - verified March 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium; Drug: olodaterol; Drug: tiotropium; Drug: tiotropium + olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium + olodaterol; Drug: tiotropium; Drug: tiotropium; Drug: olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention: Behavioral: Balance training program
Sponsors: West Park Healthcare Centre; Roger Goldstein; Ontario Lung Association
Recruiting - verified August 2011 - Condition: Acute Exacerbation of Chronic Obstructive Airways Disease
Interventions: Procedure: seamless discharge; Procedure: Usual care
Sponsors: Ward of the 21st Century; Ward of the 21st Century; Canadian Institutes of Health Research (CIHR); Alberta Health Services
Not yet recruiting - verified October 2010 - Condition: COPD Exacerbation
Interventions: Device: Automated settings on the oxygen delivery device; Device: Manual settings with FreeO2 system in collection mode
Sponsors: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec; Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Recruiting - verified May 2011 - Conditions: Ischemic Heart Disease; Heart Failure; Chronic Kidney Disease; Diabetes; Chronic Obstructive Pulmonary Disease
Intervention: Behavioral: iCDM
Sponsors: Simon Fraser University; Simon Fraser University; Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research
Recruiting - verified April 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Roflumilast; Drug: Placebo
Sponsors: Nycomed; Nycomed
Recruiting - verified May 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: PH-797804; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Respiratory Muscle Blood Flow
Interventions: Other: Near Infrared Spectroscopy; Other: Near Infrared Spectroscopy
Sponsors: University of British Columbia; University of British Columbia
Not yet recruiting - verified December 2011 - Conditions: Pulmonary Disease, Chronic Obstructive; Cardiovascular Disease
Interventions: Drug: fluticasone furoate/vilanterol; Drug: fluticasone furoate; Drug: vilanterol; Other: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: MedImmune LLC; MedImmune LLC
Recruiting - verified March 2012 - Condition: Lung Diseases
Interventions: Device: Exercise DVD; Behavioral: Usual Care
Sponsors: Capital District Health Authority, Canada; Capital District Health Authority, Canada; Capital Health, Canada
Recruiting - verified July 2011 - Conditions: Osteoporosis; Obstructive Lung Disease
Intervention:
Sponsors: University of British Columbia; University of British Columbia
Recruiting - verified November 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: simvastatin; Drug: Placebo
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Conditions: Chronic Obstructive Pulmonary Disease; Nocturnal Desaturation
Interventions: Device: Concentrator; Device: Sham concentrator
Sponsors: Laval University; Laval University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: tiotropium; Drug: long acting beta agonist
Sponsors: University of Alberta; University of Alberta; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified July 2011 - Conditions: Asthma; COPD
Intervention: Drug: salbutamol
Sponsors: University of Saskatchewan; University of Saskatchewan
Recruiting - verified May 2012 - Condition: Chronic Obstructive Pulmonary Disease
Intervention:
Sponsors: St. Joseph's Healthcare Hamilton; St. Joseph's Healthcare Hamilton
Recruiting - verified July 2011
 |
Join Clinical Trials in Florida |
